4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-25-000063
Chief Business Officer sold 1,394 shares at $14.23 ($19,837)
From the SEC's structured data for this filing
Trades in this filing
Luu Brendan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Sale : show line 1 in the form | −1,394 | $14.23 | $19,837 | 38,329 | D |
| Open-market sales · 1,394 sh · avg $14.23 · $19,837 | ||||||
Loading xslF345X05/form4.xml…